
### [MONDO:0018413](http://purl.obolibrary.org/obo/MONDO_0018413)
**Label:** rare female infertility due to an anomaly of ovarian function of genetic origin

**Subclasses:** [MONDO:0019525](http://purl.obolibrary.org/obo/MONDO_0019525) (tetrasomy X), [MONDO:0012520](http://purl.obolibrary.org/obo/MONDO_0012520) (insulin-resistance syndrome type A), [MONDO:0010012](http://purl.obolibrary.org/obo/MONDO_0010012) (autoimmune polyendocrinopathy type 2), [MONDO:0012387](http://purl.obolibrary.org/obo/MONDO_0012387) (osteosclerosis-ichthyosis-premature ovarian failure syndrome), [MONDO:0007201](http://purl.obolibrary.org/obo/MONDO_0007201) (blepharophimosis, ptosis, and epicanthus inversus syndrome), [MONDO:0018066](http://purl.obolibrary.org/obo/MONDO_0018066) (trisomy X), [MONDO:0009411](http://purl.obolibrary.org/obo/MONDO_0009411) (autoimmune polyendocrine syndrome type 1), [MONDO:0009258](http://purl.obolibrary.org/obo/MONDO_0009258) (classic galactosemia), [MONDO:0016859](http://purl.obolibrary.org/obo/MONDO_0016859) (blepharophimosis-epicanthus inversus-ptosis due to copy number variations), [MONDO:0019926](http://purl.obolibrary.org/obo/MONDO_0019926) (X small rings), [MONDO:0016858](http://purl.obolibrary.org/obo/MONDO_0016858) (blepharophimosis-epicanthus inversus-ptosis due to a point mutation syndrome), [MONDO:0016857](http://purl.obolibrary.org/obo/MONDO_0016857) (blepharophimosis-epicanthus inversus-ptosis due to 3q23 rearrangement syndrome), 

**Mapped go classes:** [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0000977](http://purl.obolibrary.org/obo/GO_0000977) (RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0090055](http://purl.obolibrary.org/obo/GO_0090055) (positive regulation of chromatin silencing at silent mating-type cassette), [GO:0008585](http://purl.obolibrary.org/obo/GO_0008585) (female gonad development), [GO:0007535](http://purl.obolibrary.org/obo/GO_0007535) (donor selection), [GO:0008108](http://purl.obolibrary.org/obo/GO_0008108) (UDP-glucose:hexose-1-phosphate uridylyltransferase activity), [GO:0003688](http://purl.obolibrary.org/obo/GO_0003688) (DNA replication origin binding), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0006959](http://purl.obolibrary.org/obo/GO_0006959) (humoral immune response), [GO:0071930](http://purl.obolibrary.org/obo/GO_0071930) (negative regulation of transcription involved in G1/S transition of mitotic cell cycle), [GO:0033499](http://purl.obolibrary.org/obo/GO_0033499) (galactose catabolic process via UDP-galactose), [GO:0032602](http://purl.obolibrary.org/obo/GO_0032602) (chemokine production), [GO:0042703](http://purl.obolibrary.org/obo/GO_0042703) (menstruation), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0005635](http://purl.obolibrary.org/obo/GO_0005635) (nuclear envelope), [GO:0048496](http://purl.obolibrary.org/obo/GO_0048496) (maintenance of animal organ identity), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0031624](http://purl.obolibrary.org/obo/GO_0031624) (ubiquitin conjugating enzyme binding), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0042393](http://purl.obolibrary.org/obo/GO_0042393) (histone binding), [GO:0031981](http://purl.obolibrary.org/obo/GO_0031981) (nuclear lumen), [GO:0097536](http://purl.obolibrary.org/obo/GO_0097536) (thymus epithelium morphogenesis), [GO:0071406](http://purl.obolibrary.org/obo/GO_0071406) (cellular response to methylmercury), [GO:0019237](http://purl.obolibrary.org/obo/GO_0019237) (centromeric DNA binding), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0009653](http://purl.obolibrary.org/obo/GO_0009653) (anatomical structure morphogenesis), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0051300](http://purl.obolibrary.org/obo/GO_0051300) (spindle pole body organization), [GO:0002458](http://purl.obolibrary.org/obo/GO_0002458) (peripheral T cell tolerance induction), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0046881](http://purl.obolibrary.org/obo/GO_0046881) (positive regulation of follicle-stimulating hormone secretion), [GO:2000410](http://purl.obolibrary.org/obo/GO_2000410) (regulation of thymocyte migration), [GO:0019101](http://purl.obolibrary.org/obo/GO_0019101) (female somatic sex determination), [GO:0060014](http://purl.obolibrary.org/obo/GO_0060014) (granulosa cell differentiation), [GO:0002074](http://purl.obolibrary.org/obo/GO_0002074) (extraocular skeletal muscle development), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0090282](http://purl.obolibrary.org/obo/GO_0090282) (positive regulation of transcription involved in G2/M transition of mitotic cell cycle), [GO:0007005](http://purl.obolibrary.org/obo/GO_0007005) (mitochondrion organization), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0061623](http://purl.obolibrary.org/obo/GO_0061623) (glycolytic process from galactose), [GO:0001541](http://purl.obolibrary.org/obo/GO_0001541) (ovarian follicle development), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005975](http://purl.obolibrary.org/obo/GO_0005975) (carbohydrate metabolic process), [GO:0003712](http://purl.obolibrary.org/obo/GO_0003712) (transcription cofactor activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0006309](http://purl.obolibrary.org/obo/GO_0006309) (apoptotic DNA fragmentation), [GO:0002509](http://purl.obolibrary.org/obo/GO_0002509) (central tolerance induction to self antigen), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0106003](http://purl.obolibrary.org/obo/GO_0106003) (amyloid-beta complex), [GO:0043548](http://purl.obolibrary.org/obo/GO_0043548) (phosphatidylinositol 3-kinase binding), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0046777](http://purl.obolibrary.org/obo/GO_0046777) (protein autophosphorylation), [GO:0006366](http://purl.obolibrary.org/obo/GO_0006366) (transcription by RNA polymerase II), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0006369](http://purl.obolibrary.org/obo/GO_0006369) (termination of RNA polymerase II transcription), [GO:0043028](http://purl.obolibrary.org/obo/GO_0043028) (cysteine-type endopeptidase regulator activity involved in apoptotic process), [GO:0007338](http://purl.obolibrary.org/obo/GO_0007338) (single fertilization), [GO:0001078](http://purl.obolibrary.org/obo/GO_0001078) (transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0045171](http://purl.obolibrary.org/obo/GO_0045171) (intercellular bridge), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0048048](http://purl.obolibrary.org/obo/GO_0048048) (embryonic eye morphogenesis), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0090419](http://purl.obolibrary.org/obo/GO_0090419) (negative regulation of transcription involved in G2/M transition of mitotic cell cycle), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0006011](http://purl.obolibrary.org/obo/GO_0006011) (UDP-glucose metabolic process), [GO:0006012](http://purl.obolibrary.org/obo/GO_0006012) (galactose metabolic process), [GO:0006258](http://purl.obolibrary.org/obo/GO_0006258) (UDP-glucose catabolic process), [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0045182](http://purl.obolibrary.org/obo/GO_0045182) (translation regulator activity), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0043560](http://purl.obolibrary.org/obo/GO_0043560) (insulin receptor substrate binding), [GO:0033686](http://purl.obolibrary.org/obo/GO_0033686) (positive regulation of luteinizing hormone secretion), [GO:0030331](http://purl.obolibrary.org/obo/GO_0030331) (estrogen receptor binding), [GO:0045060](http://purl.obolibrary.org/obo/GO_0045060) (negative thymic T cell selection), [GO:0060065](http://purl.obolibrary.org/obo/GO_0060065) (uterus development), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:1903468](http://purl.obolibrary.org/obo/GO_1903468) (positive regulation of DNA replication initiation), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0006338](http://purl.obolibrary.org/obo/GO_0006338) (chromatin remodeling), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0016779](http://purl.obolibrary.org/obo/GO_0016779) (nucleotidyltransferase activity), [GO:0034244](http://purl.obolibrary.org/obo/GO_0034244) (negative regulation of transcription elongation from RNA polymerase II promoter), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0048589](http://purl.obolibrary.org/obo/GO_0048589) (developmental growth), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0031124](http://purl.obolibrary.org/obo/GO_0031124) (mRNA 3'-end processing), [GO:0034599](http://purl.obolibrary.org/obo/GO_0034599) (cellular response to oxidative stress), [GO:2000221](http://purl.obolibrary.org/obo/GO_2000221) (negative regulation of pseudohyphal growth), [GO:0032298](http://purl.obolibrary.org/obo/GO_0032298) (positive regulation of DNA-dependent DNA replication initiation), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), 

**Class expressions from DL-Learner:**

- Thing 53.89%
- [GO:0031981](http://purl.obolibrary.org/obo/GO_0031981) (nuclear lumen) 51.35%
- [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus) 51.35%
- [GO:0005635](http://purl.obolibrary.org/obo/GO_0005635) (nuclear envelope) 51.35%
- [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular) 51.35%
- [GO:0031975](http://purl.obolibrary.org/obo/GO_0031975) (envelope) and [GO:0044428](http://purl.obolibrary.org/obo/GO_0044428) (nuclear part) 51.35%
- [GO:0031967](http://purl.obolibrary.org/obo/GO_0031967) (organelle envelope) and [GO:0044428](http://purl.obolibrary.org/obo/GO_0044428) (nuclear part) 51.35%
- [GO:0031975](http://purl.obolibrary.org/obo/GO_0031975) (envelope) 36.71%
- [GO:0031967](http://purl.obolibrary.org/obo/GO_0031967) (organelle envelope) 36.71%
- [GO:0031975](http://purl.obolibrary.org/obo/GO_0031975) (envelope) and [GO:0044446](http://purl.obolibrary.org/obo/GO_0044446) (intracellular organelle part) 36.71%
- [GO:0031975](http://purl.obolibrary.org/obo/GO_0031975) (envelope) and [GO:0044424](http://purl.obolibrary.org/obo/GO_0044424) (intracellular part) 36.71%
- [GO:0031975](http://purl.obolibrary.org/obo/GO_0031975) (envelope) and [GO:0044422](http://purl.obolibrary.org/obo/GO_0044422) (organelle part) 36.71%
- [GO:0031967](http://purl.obolibrary.org/obo/GO_0031967) (organelle envelope) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 36.71%
- [GO:0031967](http://purl.obolibrary.org/obo/GO_0031967) (organelle envelope) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 36.71%
- [GO:0031967](http://purl.obolibrary.org/obo/GO_0031967) (organelle envelope) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 36.71%


